Celemics, Inc. (KOSDAQ:331920)
South Korea · Delayed Price · Currency is KRW 12,850
0.00 (0.00%)
At close: Apr 3, 2026
Celemics Revenue
In the year 2025, Celemics had annual revenue of 5.77B KRW, down -14.16%. Celemics had revenue of 1.66B in the quarter ending December 31, 2025, a decrease of -18.04%.
Revenue
5.77B
Revenue Growth
-14.16%
P/S Ratio
18.19
Revenue / Employee
144.19M
Employees
40
Market Cap
104.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.77B | -951.36M | -14.16% |
| Dec 31, 2024 | 6.72B | 141.42M | 2.15% |
| Dec 31, 2023 | 6.58B | -2.15B | -24.65% |
| Dec 31, 2022 | 8.73B | 7.17B | 461.56% |
| Dec 31, 2016 | 1.55B | 812.79M | 109.60% |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 114.25B |
| Synergy Innovation | 113.05B |
| Corentec | 100.43B |
| M.I.TECH Co.,Ltd | 67.15B |
| BIOBIJOU | 28.49B |
| Alpha AI | 25.98B |
| Sanigen Co. | 15.35B |
| Finemedix | 9.52B |